Pharma: Eli Lilly has agreed to acquire cancer drug maker Kelonia for a deal valued at up to $7 billion.
🚀 Exciting news from Kelonia! We're pioneering in vivo CAR-T technology, empowering patients' T-cells to target and combat cancer directly within the body. Stay tuned for more updates on this groundbreaking advancement in cancer treatment! #CancerResearch #Innovation
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
